Skip to content

Reconstruction and Prediction Modeling of Immune Function in Stable Patients after Renal Transplantation

Establishment and Clinical Application of a Predictive Model for TBNK Distribution in Stable Patients after Renal Transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068666
Enrollment
Unknown
Registered
2023-02-27
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Transplantation

Interventions

Case series:None

Sponsors

Transplantation Center, The Third Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria for stable patients after renal transplantation were: patients received allogeneic renal transplantation at our center during 2015/1/1-2021/12/31; with receptor immune function status evaluation test at our center during 2017/1/1-2021/12/31; with complete clinical data; The inclusion criteria for infected or rejected patients after renal transplantation were:patients received allogeneic renal transplantation at our center during 2015/1/1-2021/12/31; with receptor immune function status evaluation test at our center during 2017/1/1-2021/12/31; with complete clinical data; with a diagnosis of infection or rejection;

Exclusion criteria

Exclusion criteria: The exclusion criteria for stable patients after renal transplantation were: patients with delayed graft function; with renal insufficiency; with infection; with rejection; with multi-Organ transplantation; The exclusion criteria for infected or rejected patients after renal transplantation were: receptor immune function status evaluation test performed more than 24 hours after admission;

Design outcomes

Primary

MeasureTime frame
Immune function;induction therapy;

Secondary

MeasureTime frame
renal function;liver function;blood routine examination;Immunosuppressive concentration;

Countries

China

Contacts

Public ContactYingzi Ming

The Third Xiangya Hospital, Central South University

myz_china@aliyun.com+86 13307318463

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026